Insider · CIK 0001709415
Alex Sapir
Files at FULC (Fulcrum Therapeutics, Inc.). First filing -, latest -.
Alex Sapir files SEC Form 4 as officer and director at FULC (Fulcrum Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alex Sapir has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock option - Right to Buyderivative | +650,000 | $0.00 | $0 | 650,000 | Feb 4, 2026 |
| Jan 24, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock option - Right to Buyderivative | +582,000 | $0.00 | $0 | 582,000 | Jan 28, 2025 |
Questions about Alex Sapir
Answered from the filings on this page, as of the latest one.
Is Alex Sapir buying or selling?
Alex Sapir has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alex Sapir's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alex Sapir has 0.
Where does Alex Sapir file Form 4?
Alex Sapir has filed Form 4 at FULC (Fulcrum Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.